Merit Medical (NASDAQ: MMSI) grants stock awards to chief legal officer

Rhea-AI Filing Summary

Merit Medical Systems’ chief legal officer and secretary, Lloyd Brian G., reported multiple equity awards in common stock. On February 26, 2026, he acquired several blocks of shares at $0.00 per share as grants, including restricted stock units that vest in scheduled annual installments, each RSU converting into one common share when vested.

Additional shares were issued after the compensation committee determined performance conditions were met for performance stock units granted on February 28, 2023. He also surrendered 5,778 shares at $78.02 per share to cover payroll and income taxes, with no shares sold in the open market. The filing also notes existing non‑qualified stock options that become exercisable in 25% annual installments beginning on various prior grant dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lloyd Brian G.

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF LEGAL OFFICER, SECRETARY

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	02/26/2026		A		10,254(1)	A	$0	44,499	D
Common Stock, No Par Value	02/26/2026		A		6,409(2)	A	$0	50,908	D
Common Stock, No Par Value	02/26/2026		A		17,002(3)	A	$0	67,910	D
Common Stock, No Par Value	02/26/2026		F		5,778(4)	D	$78.02	62,132	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$37.71							02/26/2021(5)	02/26/2027	Common Stock	16,722		16,722	D
Non-qualified stock options (right to buy)	$56.25							03/19/2022(6)	03/19/2028	Common Stock	9,681		9,681	D
Non-qualified stock options (right to buy)	$65.03							02/28/2023(7)	02/28/2029	Common Stock	8,094		8,094	D
Non-qualified stock options (right to buy)	$70.58							02/28/2024(8)	02/28/2030	Common Stock	13,576		13,576	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

2. Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

3. These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

4. The Reporting Person surrendered 5,778 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

5. Become exercisable in equal annual installments of 25% commencing on 02/26/2021.

6. Become exercisable in equal annual installments of 25% commencing on 03/19/2022.

7. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.

8. Become exercisable in equal annual installments of 25% commencing on 02/28/2024.

	/s/ Brian G.Lloyd	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MMSI’s Lloyd Brian G. report on this Form 4?

He reported several stock awards and a tax-related share surrender. The awards included restricted and performance-based shares at $0.00 per share, plus 5,778 shares surrendered at $78.02 each to cover taxes, with no open-market sales.

Were the MMSI insider’s recent share transactions open-market buys or sells?

They were not open-market trades. Shares were acquired through equity awards and performance stock units, while 5,778 shares were surrendered back to the issuer for payroll and income taxes, explicitly stating no shares were sold in the open market.

How do the new RSU grants to MMSI’s chief legal officer vest?

The RSUs vest in scheduled future installments. One grant vests in three equal annual installments on each of the first three anniversaries, and another vests in two equal installments on the second and third anniversaries, contingent on continued service through each vesting date.

What is the significance of the performance stock units mentioned in the MMSI Form 4?

Some shares were issued when the compensation committee determined performance conditions were satisfied. These shares came from performance stock units originally granted on February 28, 2023, meaning the executive received common stock after meeting predefined performance criteria set under that award.

How were taxes handled on the MMSI insider’s recent stock awards?

Taxes were covered through share surrender rather than cash. The reporting person surrendered 5,778 shares of common stock back to the issuer for payroll and income taxes, and the disclosure clarifies that no shares involved in this withholding were sold on the open market.

What does the Form 4 say about the MMSI insider’s stock options?

The filing lists non-qualified stock options as existing holdings. Footnotes state these options become exercisable in 25% annual installments beginning on specific dates in 2021, 2022, 2023, and 2024, reflecting a multi-year vesting schedule tied to earlier grants.